FDA Brief

Warning letters Drugs

FDA warning letter to

Ezra Holdco LLC dba Ezra

LowIssued Jun 8Posted Jun 16Center for Drug Evaluation and Research (CDER)

FDA says Ezra's website misbrands compounded semaglutide and tirzepatide by labeling them as Ezra-made when they are not.

What happened

FDA reviewed Ezra's website in May 2026 and found compounded semaglutide and tirzepatide products offered for sale. FDA said the pictured labels identify "Ezra" in a way that suggests Ezra is the compounder when it is not, making the products misbranded.

What FDA found

  1. The website labels for compounded semaglutide and tirzepatide show "Ezra," suggesting Ezra made the drugs when it did not, so the labeling is false or misleading.

    FD&C Act §502(a) [21 U.S.C. §352(a)]; 21 C.F.R. §201.1(h)(2)
  2. The advertising or promotion of the compounded semaglutide and tirzepatide products is false or misleading because of the same Ezra labeling.

    FD&C Act §502(bb) [21 U.S.C. §352(bb)]
  3. The misbranded compounded drugs were introduced or delivered for introduction into interstate commerce.

    FD&C Act §301(a) [21 U.S.C. §331(a)]

What FDA wants

FDA tells Ezra to respond in writing within 15 business days to CDER's Office of Compounding Quality and Compliance, identify the entities that make the compounded drugs, provide sample labeling, and correct or remove false or misleading website claims.

Who should pay attention

  • telehealth companies selling compounded semaglutide or tirzepatide
  • marketers that use their own brand on compounded drug labels
  • compounding pharmacies and contract manufacturers supplying these products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low